Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Multiple

<< Previous

Bullboard Posts

Next >>

Comment by Kayz88on Jan 16, 2024 5:05pm

196 Views

Post# 35830014

RE:Multiple

Here's what ChatGPT thinks:

Possible Valuation Range:

Assuming an annual revenue of $118 million, and considering the breakthrough status, you might look at a multiple ranging from 10x to even higher, such as 12x-15x or more, depending on the factors mentioned. This would suggest a valuation range of approximately $1.18 billion to $1.77 billion or potentially higher.
-
Rule of thumb for TLT is $4 = $1 billion market cap. So somewhere between: $4.72 and $7.08 per share. Assuming we received BTD and are able to capture 7% of the market.

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features